Endothelin-1 Overexpression Exaggerates Diabetes-Induced Endothelial Dysfunction by Altering Oxidative Stress

Area of Science:

• Vascular Biology
• Endocrinology
• Diabetology

Background:

• Increased endothelin-1 (ET-1) expression is linked to endothelial dysfunction and oxidative stress.
• Elevated plasma ET-1 is observed in diabetes mellitus patients.
• Endothelial dysfunction often precedes vascular complications in diabetes.

Purpose of the Study:

• To investigate if endothelin-1 (ET-1) overexpression in the endothelium exacerbates diabetes-induced endothelial dysfunction.
• To determine the impact of endothelial ET-1 overexpression on vascular oxidative stress and remodeling in diabetes.

Main Methods:

• Diabetes was induced in wild-type (WT) and endothelium-specific ET-1 overexpressing (eET-1) mice using streptozotocin.
• Endothelial function of small mesenteric arteries was assessed using pressurized myography.
• Reactive oxygen species (ROS) production and gene expression (eNOS, SOD1, SOD2) were quantified.

Main Results:

• Diabetes reduced endothelium-dependent vasodilation by 24% in WT mice and further by 12% in eET-1 mice.
• Vascular ROS production was significantly increased in diabetic eET-1 mice compared to diabetic WT mice.
• Diabetes decreased endothelial nitric oxide synthase (eNOS) expression in eET-1 mice but not WT mice, while antioxidant enzyme expression patterns differed between groups.

Conclusions:

• Endothelin-1 (ET-1) overexpression exacerbates diabetes-induced endothelial dysfunction.
• This exacerbation may be attributed to decreased eNOS expression, increased vascular oxidative stress, and diminished antioxidant capacity.
• Targeting ET-1 may offer a therapeutic strategy for diabetic vascular complications.